Treats urinary tract infections. NDA 16620, held by Almatica. Nitrofurantoin, Macrocrystalline.
As of Nov 13, 2026, NDA 16620 (Macrodantin), held by Almatica, was first approved by FDA on Jun 5, 1970, with 45 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Nitrofurantoin Macrocrystals is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Nitrofurantoin Macrocrystals and other antibacterial drugs, Nitrofurantoin Macrocrystals should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 5, 1970 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Macrodantin50MG · capsule;oral | Nitrofurantoin, Macrocrystalline | DiscontinuedReference drug |
| Macrodantin100MG · capsule;oral | Nitrofurantoin, Macrocrystalline | DiscontinuedReference drug |
| Macrodantin25MG · capsule;oral | Nitrofurantoin, Macrocrystalline | DiscontinuedReference drug |
| Jan 21, 2021 | Supplement 76Labeling · Standard review | Approved | |
| Oct 15, 2015 | Supplement 74Manufacturing · Standard review | Approved | None posted |
| Oct 2, 2015 | Supplement 73Manufacturing · Standard review | Approved | None posted |
| Sep 6, 2013 | Supplement 72Labeling · Standard review | Approved | |
| Jun 6, 2011 | Supplement 70Labeling · Standard review | Approved | |
| Mar 5, 2009 | Supplement 68Labeling · Standard review | Approved | |
| Sep 14, 2007 | Supplement 67Labeling · Standard review | Approved | |
| Mar 29, 2004 | Supplement 65Labeling · Standard review | Approved | |
| Feb 4, 2003 | Supplement 64Labeling · Standard review | Approved | |
| Oct 21, 1998 | Supplement 63Manufacturing · Standard review | Approved | |
| Feb 17, 1998 | Supplement 58Labeling · Standard review | Approved | None posted |
| Feb 17, 1998 | Supplement 56Labeling · Standard review | Approved | None posted |
| Jul 16, 1997 | Supplement 62Labeling · Standard review | Approved | |
| Mar 27, 1997 | Supplement 61Labeling · Standard review | Approved | None posted |
| Jul 30, 1996 | Supplement 60Manufacturing · Standard review | Approved | None posted |
| Mar 7, 1996 | Supplement 59Manufacturing · Standard review | Approved | |
| Aug 9, 1993 | Supplement 57Manufacturing · Standard review | Approved | |
| May 19, 1993 | Supplement 39Labeling | Approved | None posted |
| May 18, 1993 | Supplement 36Labeling | Approved | None posted |
| Dec 8, 1992 | Supplement 55Manufacturing · Standard review | Approved | |
| Dec 8, 1992 | Supplement 54Manufacturing · Standard review | Approved | |
| Dec 8, 1992 | Supplement 53Manufacturing · Standard review | Approved | |
| Dec 8, 1992 | Supplement 52Manufacturing · Standard review | Approved | None posted |
| Apr 10, 1991 | Supplement 51Manufacturing · Standard review | Approved | None posted |
| Sep 11, 1990 | Supplement 49Manufacturing · Standard review | Approved | None posted |
| Jul 9, 1990 | Supplement 50Manufacturing · Standard review | Approved | None posted |
| Jan 3, 1989 | Supplement 47Manufacturing · Standard review | Approved | |
| May 13, 1988 | Supplement 45Labeling | Approved | |
| Jul 9, 1984 | Supplement 38Manufacturing · Standard review | Approved | None posted |
| Jun 2, 1983 | Supplement 37Manufacturing · Standard review | Approved | None posted |
| Oct 15, 1982 | Supplement 31Labeling | Approved | None posted |
| May 13, 1982 | Supplement 35Manufacturing · Standard review | Approved | None posted |
| Dec 12, 1980 | Supplement 32Labeling | Approved | None posted |
| Aug 14, 1980 | Supplement 30Manufacturing · Standard review | Approved | None posted |
| May 20, 1980 | Supplement 28Manufacturing · Standard review | Approved | None posted |
| Dec 18, 1979 | Supplement 26Labeling | Approved | None posted |
| Jul 26, 1979 | Supplement 25Manufacturing · Standard review | Approved | None posted |
| Jul 16, 1979 | Supplement 27Manufacturing · Standard review | Approved | None posted |
| Jul 28, 1978 | Supplement 23Labeling | Approved | None posted |
| May 13, 1977 | Supplement 21Manufacturing · Standard review | Approved | None posted |
| Mar 21, 1977 | Supplement 20Manufacturing · Standard review | Approved | |
| Nov 22, 1976 | Supplement 19Manufacturing · Standard review | Approved | |
| Jul 21, 1976 | Supplement 18Manufacturing · Standard review | Approved | |
| Jul 21, 1976 | Supplement 17Manufacturing · Standard review | Approved | |
| Jul 15, 1976 | Supplement 16Manufacturing · Standard review | Approved | |
| Jun 5, 1970 | Original applicationNew dosage form · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters